Skip to main content
CAMBRIDGE NUTRITIONAL SCIENCES PLC logo

CAMBRIDGE NUTRITIONAL SCIENCES PLC — Investor Relations & Filings

Ticker · CNSL ISIN · GB00B1VCP282 LEI · 2138007U9P4BTZTYIR92 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2021-05-05 Regulatory Filings
Country GB United Kingdom
Listing IL CNSL

About CAMBRIDGE NUTRITIONAL SCIENCES PLC

https://www.cnsplc.com/

Cambridge Nutritional Sciences PLC is a medical diagnostics company that develops, manufactures, and distributes products focused on promoting a personalised approach to health. The company specialises in a range of tests associated with food sensitivity and gut health. Utilising advanced diagnostic technology, its products are designed for use by healthcare professionals and their patients to identify potential food reactions and guide lifestyle and dietary changes. The company's goal is to enable individuals to improve their long-term health and wellbeing by understanding how their diet may be contributing to various health issues.

Recent filings

Filing Released Lang Actions
Positive data for Mologic COVID-19 antigen test
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service. It announces positive independent verification data for a COVID-19 test produced by Omega Diagnostics. It provides a link to the external report rather than being the report itself, and it is under 5,000 characters. As it is a general corporate announcement that does not fit into specific categories like financial results or governance, it falls under the RNS regulatory filing category.
2021-05-05 English
Exercise of Options and Total Voting Rights
Share Issue/Capital Change Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding the allotment of new ordinary shares following the exercise of share options. It explicitly mentions the total number of voting rights post-admission. This falls under the category of share issuance and capital changes.
2021-04-30 English
Launch of VISITECT® COVID-19 Antigen & Update
Regulatory Filings Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement from Omega Diagnostics Group PLC regarding the product launch of their VISITECT COVID-19 Antigen test and an update on a government contract. It is a corporate news release providing operational updates rather than a formal financial report, audit, or proxy statement. As it is a general regulatory announcement that does not fit into more specific categories like M&A or Director's Dealing, it is classified as a Regulatory Filing (RNS).
2021-04-30 English
Director/PDMR Shareholding and Total Voting Rights
Director's Dealing Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC regarding the exercise of share options by a PDMR (John Bannister) and the subsequent allotment of new ordinary shares. It includes a formal 'Notification of a Transaction' table as required by the EU Market Abuse Regulation. While it mentions total voting rights, the primary purpose is to report a director's share transaction and the resulting change in share capital. Given the specific nature of the transaction by a PDMR, 'DIRS' (Director's Dealing) is the most accurate classification.
2021-04-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is an RNS (Regulatory News Service) announcement regarding a 'Director/PDMR Shareholding'. It explicitly details a transaction by a person discharging managerial responsibilities (Derek Brady, Group Strategic Sourcing Director) involving the sale of company shares. This falls directly under the definition of 'Director's Dealing' (DIRS).
2021-04-19 English
Director/PDMR Shareholding and Total Voting Rights
Director's Dealing Classification · 1% confidence The document is an RNS announcement from Omega Diagnostics Group PLC detailing a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director exercising share options and subsequently selling those shares. It includes the required regulatory disclosure table under Article 19(1) of the Market Abuse Regulation. While it mentions total voting rights, the primary purpose is the disclosure of a director's share transaction, which falls under the 'Director's Dealing' category.
2021-03-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.